GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » YS Biopharma Co Ltd (NAS:YS) » Definitions » Revenue

YS Biopharma Co (YS Biopharma Co) Revenue : $79.17 Mil (TTM As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is YS Biopharma Co Revenue?

YS Biopharma Co's revenue for the six months ended in Sep. 2023 was $37.42 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $79.17 Mil. YS Biopharma Co's Revenue per Share for the six months ended in Sep. 2023 was $0.40. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.85.

Warning Sign:

YS Biopharma Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of YS Biopharma Co was -16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


YS Biopharma Co Revenue Historical Data

The historical data trend for YS Biopharma Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YS Biopharma Co Revenue Chart

YS Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Revenue
39.48 79.27 99.73

YS Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Revenue Get a 7-Day Free Trial 41.73 36.81 56.92 41.75 37.42

Competitive Comparison of YS Biopharma Co's Revenue

For the Biotechnology subindustry, YS Biopharma Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YS Biopharma Co's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, YS Biopharma Co's Revenue distribution charts can be found below:

* The bar in red indicates where YS Biopharma Co's Revenue falls into.



YS Biopharma Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $79.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YS Biopharma Co  (NAS:YS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


YS Biopharma Co Revenue Related Terms

Thank you for viewing the detailed overview of YS Biopharma Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


YS Biopharma Co (YS Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.

YS Biopharma Co (YS Biopharma Co) Headlines

From GuruFocus